Skip to main content

Anthony Hickey Named Director of UNC Catalyst for Rare Diseases

January 29, 2019

Anthony Hickey, Ph.D., has returned to the UNC Eshelman School of Pharmacy to head up the UNC Catalyst for Rare Diseases. Hickey, a professor in the Division of Pharmacoengineering and Molecular Pharmaceutics from 1993 until 2010, returns to the School after a stint at the Research Triangle Institute, where he was program director in inhaled therapeutics at the Center for Aerosol and Nanomaterials Engineering. Hickey earned his Ph.D. in pharmaceutical sciences from Aston University in Birmingham, U.K. After five years on faculty at the University of Illinois at Chicago, he came to the School in 1993. Hickey is the founder … Continued

Sjoquist Wins ACCP Education and Training Poster Competition

January 28, 2019

Laura Sjoquist, Pharm.D., a postdoctoral fellow at the UNC Eshelman School of Pharmacy, won first place in the 2018 American College of Clinical Pharmacy Education and Training PRN poster competition. Sjoquist is the experiential programs academic fellow in the Division of Practice Advancement and Clinical Education at the School. She received the award after presenting at the American College of Clinical Pharmacy Global Conference in Seattle in October. The research poster, entitled “An Exploration of Student Progression Toward Practice Readiness,” was co-authored by PACE faculty members Antonio Bush, Ph.D., Macary Marciniak, Pharm.D., and Nicole Pinelli Reitter, Pharm.D. The qualitative research … Continued

Skrajna Awarded American Cancer Society Postdoc Fellowship

January 24, 2019

Aleksandra Skrajna, Ph.D., a postdoctoral researcher at the UNC Eshelman School of Pharmacy and UNC Lineberger Comprehensive Cancer Center, has been awarded a three-year post-doctoral fellowship from the American Cancer Society. The fellowship, worth over $150,000 over three years, supports the training of promising post-doctoral scientists in preparation for independent careers in cancer research. Skrajna works in the lab of Robert McGinty, M.D., Ph.D., an assistant professor at the School and an associate Lineberger member. Skrajna’s research is focused on how enzymes bind to our genetic material in cells to ensure that our genes are expressed appropriately. “By understanding how … Continued

Anselmo Wins Pharmaceutics Young Investigator Award

January 14, 2019

  Aaron Anselmo, Ph.D., has been named the 2018 Young Investigator Award winner by Pharmaceutics. Anselmo is an assistant professor in the Division of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy. His research focuses on developing pharmaceutics-based approaches to deliver therapeutic bacteria, combining pharmaceutics fundamentals to inform the engineering of new delivery systems for the microbiota. This work overlaps microbiology and microbe ecology, pharmaceutics, engineering and drug delivery to develop new strategies for treating microbiota-related disorders. Anselmo received his B.S. degree in chemical engineering from Rensselaer Polytechnic Institute and his Ph.D. in Chemical Engineering at the … Continued

Anselmo Authors Review of Biologics Delivery Strategies

December 5, 2018

Biological pharmaceutical products are becoming increasingly utilized in the clinic, setting off corresponding changes in the development of drug delivery technologies, according to a new paper from the UNC Eshelman School of Pharmacy. The review, written by Aaron Anselmo, Ph.D., and collaborators, was published in Nature Reviews Drug Discovery on Nov. 30. Anselmo is an assistant professor in the School’s Division of Pharmacoengineering and Molecular Pharmaceutics. His paper, “Non-Invasive Delivery Strategies for Biologics,” assesses the academic and industry efforts to develop new delivery strategies for biologics. Biologics represent the cutting edge of biomedical research, and have a much broader range … Continued

Alan Kinlaw Joins DPOP as Assistant Professor

November 8, 2018

Alan Kinlaw, Ph.D., M.S.P.H., has been hired as a tenure-track assistant professor at the UNC Eshelman School of Pharmacy, in the Division of Pharmaceutical Outcomes and Policy. Kinlaw joins the School after a post-doctoral fellowship at UNC’s Cecil G. Sheps Center for Health Services Research, where he worked under Timothy Carey, M.D., M.P.H. He earned his Ph.D. in 2016 and his M.S.P.H. in 2012, both from the Department of Epidemiology at the UNC Gillings School of Global Public Health. Kinlaw is also a graduate of N.C. State University, where he earned undergraduate degrees in textile engineering and French. Kinlaw’s research … Continued

UNC Researchers Develop Platform for Universal Flu Vaccine

November 5, 2018

Researchers at the University of North Carolina at Chapel Hill are developing a universal flu vaccine which could be effective against multiple influenza strains and in multiple flu seasons. In the United States, up to 35.6 million people become infected with the flu each year, resulting in up to 710,000 hospitalizations and 56,000 flu related deaths, according to the Centers for Disease Control and Prevention. The effectiveness of seasonal flu vaccines can vary from year to year — with some years, such as 2004, as low as 10 percent efficacy. In a study published by the Journal of Controlled Release, … Continued

Ainslie Awarded $1.89M NIH Grant to Develop Multiple Sclerosis Vaccine

October 16, 2018

The National Institutes of Health awarded a grant of nearly $2 million to Kristy Ainslie, Ph.D., for a proposal to develop a therapeutic vaccine for multiple sclerosis. Ainslie is an associate professor in the Division of Pharmacoengineering and Molecular Pharmaceutics at the UNC Eshelman School of Pharmacy, as well as an adjunct associate professor in the UNC Department of Biomedical Engineering and the Department of Microbiology and Immunology. She said the project’s long-term goal is to design a biodegradable, tunable particle system to serve as a therapeutic vaccine to alleviate multiple sclerosis. Multiple sclerosis is a disease of the central … Continued

Ferreri Awarded $3M CDC Grant for Study on Opioid Use

October 10, 2018

The Centers for Disease Control awarded a $3 million grant to Stefanie Ferreri, Pharm.D., for a study on screening older adults who use prescription opioids and are at risk for falls. Ferreri is the executive vice chair of the Division of Practice Advancement and Clinical Education at the UNC Eshelman School of Pharmacy and a clinical professor. Her study will engage patients within the UNC Health Care System who are 65 years of age or older and taking either an opioid or benzodiazepine, with the objective of implementing a de-prescribing medication protocol to protect older adults at risk of falls. … Continued

Gonzalez Receives $2M NIH Grant for Project on Childhood Obesity

October 9, 2018

Daniel Gonzalez, Pharm.D., Ph.D., an assistant professor at the UNC Eshelman School of Pharmacy in the Division of Pharmacotherapy and Experimental Therapeutics, received a $2 million NIH Research Project Grant for research focused on drug dosing in children with obesity. Gonzalez’s proposal aims to find a systematic approach to the development and evaluation of physiologically-based pharmacokinetic models to help treat children with obesity. These models are mathematical constructs that incorporate physiologic and body composition changes during childhood. “The majority of drugs prescribed to children with obesity lack recommendations for appropriate dosing for size,” Gonzalez said. “Physiologically-based pharmacokinetic models can be used … Continued